Elevance Renewable Sciences Announces New Chief Financial Officer
September 6, 2011 (Woodridge, IL)
Elevance Renewable Sciences, Inc. announced today that David Kelsey has been named chief financial officer (CFO).
“We are pleased to welcome David to our company,” said K’Lynne Johnson, CEO of Elevance. “David brings a strong breadth of experience to our CFO position. His background is a great fit with our overall strategy, operations and team.”
Kelsey will be responsible for leading the financial growth and management of the company as it expands its biorefineries and partnerships across the globe.
Kelsey was most recently senior vice president and CFO at Sealed Air Corporation, a Fortune 500 company and a leader in global manufacturing of a wide range of food, protective and specialty packaging materials and systems. Prior to joining Sealed Air, David served as CFO of two small cap growth companies, one of which was privately owned and one of which was publicly traded.
Early in his career, Kelsey held various executive positions with General Electric and GE Capital, including senior vice president of GE Capital Equity Funding Group where he led investment teams and managed project and growth financing for various private and public companies within its portfolio. He currently serves as a director of Granite Construction, Inc., one of the largest heavy civil contractors in the United States.
Kelsey has a Bachelor of Science and Engineering from Princeton University and an MBA from Harvard University.
About Elevance Renewable Sciences, Inc.
Headquartered in Woodridge, Ill., Elevance Renewable Sciences, Inc. creates novel specialty chemicals from natural oils for use in personal care products, detergents and cleaners, lubricants and additives, engineered polymers, and other specialty chemicals markets. Commercial shipments from the company’s first biorefinery, a 180,000 MT joint venture with Wilmar International Limited located in Gresik, Indonesia, began earlier this year. The biorefinery is the first based on Elevance’s proprietary metathesis technology with a Natchez, Miss., biorefinery scheduled to be the second biorefinery with a capacity of 280,000 MT.